Table 1.
Classification | Expression | Distribution (%) |
---|---|---|
Luminal A | ER/PR+, HER2− | ~65 |
Luminal B | ER/PR+, HER2+/− | ~15 |
HER2-type | ER/PR−, HER2+ | ~5 |
Triple-negative | ER/PR−, HER2− | ~15 |
According to [3, 5, 8] (http://ww5.komen.org/BreastCancer/SubtypesofBreastCancer.html).